ScholarWorks@Korea University: Lee, Ki ho

Detailed Information

Lee, Ki ho (이기호)

College of Pharmacy (Department of Pharmaceutical Science)

Research Area

Tel 044-860-1616
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

pharmacokinetics:6||metabolism:6||Melanogenesis:4||alphaMSH:3||metabolite identification:3||lipidsoluble ginseng extract:3||Cytotoxicity:3||Imino DielsAlder reaction:3||Bioisostere:2||Isoxazole:2||Nitric oxide:2||Perifosine:2||Cytochrome P450:2||Cytotoxic agents:2||4OMethylhonokiol:2||histone deacetylase inhibitor:2||conjugation:2||Caffeamide:2||Drug metabolism:2||RhoB:2||LW6:2||apoptosis:2||NSC126188:2||Anticancer activity:2||Mechanismbased inhibition:2||4Omethylhonokiol:2||Reactive metabolites:2||drug metabolism:1||Hantzschtype onepot approach:1||5hydroxy2 &apos:1||isobutyl streptochlorin:1||Thiazole:1||Statins:1||AIMP2:1||13HBenzo[f]chromeno[4,3b]:1||1,2,3,4Tetrahydroquinolines:1||human cancer cell lines:1||thioctic acid:1||Inhibition of NFkappa B transcriptional activity:1||UGT:1||Obesity:1||lung metastasis:1||dimethoxycurcumin:1||Nonprotein sulfhydryl:1||Gastric sensory afferents:1||cell cycle arrest:1||Property:1||fatty liver disease:1||human tumor xenograft:1||Prolyl hydroxylation:1||Adamantane:1||NHeterocycles:1||Multicomponent Reaction:1||hypoxiainducible factor1&:1||predictive multiple reaction monitoringinformation dependent acquisitionenhanced product ion:1||Caco2 cells:1||veterinary drugs:1||advanced methods:1||NFkappa B signaling:1||chicken liver microsomes:1||Prostate cancer:1||Celecoxib:1||Impurities:1||homoisoflavanone:1||Dual human Topoisomerase I and II alpha inhibition:1||Nitrones:1||Nitrosobenzene:1||Sulfonated benzo[f][1,7]naphthyridines:1||CC bonds formation:1||streptochlorin:1||Reaction phenotyping:1||Plumbagin:1||Human Topoisomerase II alpha inhibitors:1||Rosuvastatin calcium:1||Atom economy:1||Onepot multicomponent reaction:1||Prodrug:1||Solubility:1||NFkappa B inactivation:1||Fimasartan:1||qualitative and quantitative analysis:1||glimepiride:1||Cyclooxygenase2:1||Anticancer agent:1||malignant breast cancer cells:1||Antiexcitotoxic activity:1||survivin:1||pyridones:1||Artemisinin:1||Aryl carbamate:1||Estrous cycle:1||Liver:1||Lycoris aurea:1||Tube formation:1||hyperlipidemia:1||Diazacyclopenta[b]anthracene5:1||HIF1α:1||Hypoxia:1||Multidrug resistance:1||Mass spectrometry:1||coronaviruses:1||natural products:1||clarithromycin:1||Wnt signaling:1||cytochrome P450:1||NBenzoylindazoles:1||Kornblum oxidation:1||13HBenzo[f]chromeno[4,3b][1,7]naphthyridines:1||parallel artificial membrane permeability assay (PAMPA):1||permeability:1||Dimer:1||Preformulation:1||Grubbs catalyst:1||PIFA:1||Antiinflammatory target:1||Xanthone:1||honokiol:1||neolignan:1||paraptosis:1||Zaltoprofen:1||Antiinflammatory:1||Magnolia officinalis:1||LPS:1||GTPase rat sarcoma (Ras):1||Aliphatic amido/sulfonamidoquaternary ammonium salts:1||microarray:1||Optimization:1||Cyclooxygenase2 (COX2):1||Growth:1||Potassium aryltrifluoroborate:1||10diones:1||Pglycoprotein:1||CatalystFree:1||liver microsomes:1||Allergy:1||Cytokine:1||flavonoids:1||prodrug:1||berberine:1||herbdrug interaction:1||SP8356:1||NArylindazole3carboxamides:1||HET0016:1||Chlorogenic acid (CGA):1||Caffeic acid:1||HMGCoA reductase inhibitor:1||lipophilic compound:1||[1,7]naphthyridines:1||docetaxel:1||oxidative dearomatization:1||Metabolic stability:1||Metabolite identification:1||Hydrazide:1||Diacylglycerol Oacyltransferase:1||Agonist:1||Antiischemic activity:1||Enantiomer:1||A248:1||amyloid:1||drug design:1||Reversibility:1||AMPactivated protein kinase:1||Ovary:1||Neolignan:1||grape extract:1||green tea extract:1||Lcarnitine:1||highfat diet:1||(aryloxyacetylamino)Benzoic acid:1||VonHippelLindau:1||mice pharmacokinetics:1||detection methods:1||Interleukin33:1||phytochemicals:1||NFkappa B nuclear translocation:1||Wound healing:1||Hepsin:1||Dipeptide:1||Pyrazole:1||Active pharmaceutical ingredient:1||Lproline:1||Transitionmetalfree:1||Atomeconomy:1||CYP4A11:1||1,3Diphenylbenzo[f][1,7] benzonaphthyrdines:1||Oncogenic:1||NMR:1||Solutol:1||cancer therapy:1||drug drug interaction:1||Pyrimidine:1||Malonamide:1||alphaMangostin:1||curcumin:1||Verbenone:1||specificity protein 1:1||GTPase RAt Sarcoma (Ras):1||histone deacetylases:1||STAT1:1||Docking:1||widdrol:1||SuzukiMiyaura crosscoupling:1||Acyl glucuronide:1||oral administration:1||Quinazoline:1||antivirals:1||1,2,3,4Tetrahydroisoquinoline:1||carbamate:1||LC/ESIHRMS:1||metabolites:1||nontargeted screening:1||GSK3 beta:1||Dual inhibition:1||Structureactivity relationship:1||Arbutin:1||cremastranone:1||Enamines:1||Metalfree:1||Laurie acid metabolism:1||betaHydroxy sulfonamide:1||DX2:1||1,3Diphenylbenzo[f][1,7]naphthyridines:1||in vitro cytotoxicity:1||Pluronic F68:1||broussonone A:1||piperazine dithioctate:1||Diacylglycerol Oacyltransferase inhibitor:1||TGR5:1||Kinetic solubility:1||Small molecule:1||prostate cancer:1||Mcl1:1||Aliphatic amidoquaternary ammonium salts:1||magnolia:1||neuroinflammation:1||IFNbeta:1||Histone deacetylases:1||Triazole:1||Drugmetabolizing enzyme:1||Estradiol:1||Cell cycle:1||Druginduced liver injury:1||anticancer:1||established human xenograft:1||anticancer effect:1||OnePot Synthesis:1||Drug discovery:1||Pharmacokinetics:1||Inhibitors:1||COVID19:1||SARSCoV2:1||baicalein:1||4Aminopyrroles:1||Skin whitening:1||FK506:1||metabolic stability:1||multilayer nanoparticles:1||cross metathesis:1||Benzofuran and 2,3dihydrobenzofuran scaffolds:1||CYP:1||Triglyceride:1||matrix metalloprotease2:1||Antioxidant activity:1||Analgesic:1||Silymarin:1||Openring form of aliphatic amidoquaternary ammonium salts:1||inhibitors:1||Metabolismdependent inhibition:1||Cancer:1||Cytotoxic activity:1||MESSA/DX5:1||ABC transporter:1||CYP3A4:1||Carboxamide:1||animalderived foods:1||alkaloids:1||Human cancer cell lines:1||CXXC5Dvl interaction:1||bioactivation:1||COX inhibitor:1||Molecular docking:1||Azomethine ylide:1||Onepot CS &:1||Molecular docking studies:1||Drug impurities:1||cassette:1||nonspecific binding:1||total synthesis:1||Amitriptyline:1||cancer invasion:1||proteasomal inhibition:1||Cerebral ischemia:1||Gastritis:1||Drugdrug interaction:1||Inhibitor:1||colon cancer:1||#945:1||hybrid triple quadrupolelinear ion trap mass spectrometer:1||extraction:1||residues:1||Oxazoloquinoline:1||erythromycin:1||Indirubin3 &apos:1||alkoxime derivatives:1||

STATISTICS: Total View :6,822,729; Today View :32,017

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE